Kalhs P - Search Results

1

Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient program.

Worel N, Rosskopf K, Neumeister P, Kasparu H, Nachbaur D, Russ G, Namberger K, Witt V, Schloegl E, Zojer N, Linkesch W, Kalhs P, Greinix HT. Worel N, et al. Among authors: kalhs p. Transfusion. 2011 May;51(5):968-75. doi: 10.1111/j.1537-2995.2010.02896.x. Epub 2010 Sep 28. Transfusion. 2011. PMID: 20880037 Clinical Trial.

2

Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning.

Worel N, Greinix HT, Supper V, Leitner G, Mitterbauer M, Rabitsch W, Fischer G, Rosenmayr A, Höcker P, Kalhs P. Worel N, et al. Among authors: kalhs p. Transfusion. 2007 Aug;47(8):1494-502. doi: 10.1111/j.1537-2995.2007.01289.x. Transfusion. 2007. PMID: 17655594

3

Frequency and prognostic value of D alloantibodies after D-mismatched allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning.

Worel N, Böhm A, Rabitsch W, Leitner G, Mitterbauer M, Kalhs P, Mayr WR, Schwartz D, Greinix HT. Worel N, et al. Among authors: kalhs p. Transfusion. 2012 Jun;52(6):1348-53. doi: 10.1111/j.1537-2995.2011.03457.x. Epub 2011 Dec 1. Transfusion. 2012. PMID: 22128859

4

Plerixafor as preemptive strategy results in high success rates in autologous stem cell mobilization failure.

Worel N, Fritsch G, Agis H, Böhm A, Engelich G, Leitner GC, Geissler K, Gleixner K, Kalhs P, Buxhofer-Ausch V, Keil F, Kopetzky G, Mayr V, Rabitsch W, Reisner R, Rosskopf K, Ruckser R, Zoghlami C, Zojer N, Greinix HT. Worel N, et al. Among authors: kalhs p. J Clin Apher. 2017 Aug;32(4):224-234. doi: 10.1002/jca.21496. Epub 2016 Aug 31. J Clin Apher. 2017. PMID: 27578390

5

Kinetics of PBPC mobilization by cyclophosphamide, as compared with that by epirubicin/paclitaxel followed by G-CSF support: implications for optimal timing of PBPC harvest.

Dettke M, Greinix HT, Kalhs P, Kührer I, Worel N, Höcker P. Dettke M, et al. Among authors: kalhs p. Transfusion. 2001 May;41(5):681-6. doi: 10.1046/j.1537-2995.2001.41050681.x. Transfusion. 2001. PMID: 11346706

6

Ex vivo expansion of long-term culture initiating marrow cells by IL-10, SCF, and IL-3.

Keil F, Elahi F, Greinix HT, Fritsch G, Louda N, Petzer AL, Prinz E, Wagner T, Kalhs P, Lechner K, Geissler K. Keil F, et al. Among authors: kalhs p. Transfusion. 2002 May;42(5):581-7. doi: 10.1046/j.1537-2995.2002.00102.x. Transfusion. 2002. PMID: 12084166

7

Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning.

Worel N, Greinix HT, Keil F, Mitterbauer M, Lechner K, Fischer G, Mayr W, Höcker P, Kalhs P. Worel N, et al. Among authors: kalhs p. Transfusion. 2002 Oct;42(10):1293-301. doi: 10.1046/j.1537-2995.2002.00209.x. Transfusion. 2002. PMID: 12423513

8

ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation.

Worel N, Kalhs P, Keil F, Prinz E, Moser K, Schulenburg A, Mitterbauer M, Mannhalter C, Mayr WR, Schwarzinger I, Höcker P, Lechner K, Greinix HT. Worel N, et al. Among authors: kalhs p. Transfusion. 2003 Aug;43(8):1153-61. doi: 10.1046/j.1537-2995.2003.00465.x. Transfusion. 2003. PMID: 12869124

9

The influence of human platelet antigen match on the success of allogeneic peripheral blood progenitor cell transplantation following a reduced-intensity conditioning regimen.

Leitner GC, Stiegler G, Kalhs P, Greinix HT, Rabitsch W, Sillaber C, Hoecker P, Panzer S. Leitner GC, et al. Among authors: kalhs p. Transfusion. 2005 Feb;45(2):195-201. doi: 10.1111/j.1537-2995.2004.04115.x. Transfusion. 2005. PMID: 15660827

10

Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity.

Worel N, Schulenburg A, Mitterbauer M, Keil F, Rabitsch W, Kalhs P, Gisslinger H, Raderer M, Geissler K, Höcker P, Zielinski CC, Oberbauer R, Greinix HT. Worel N, et al. Among authors: kalhs p. Wien Klin Wochenschr. 2006 Feb;118(1-2):49-53. doi: 10.1007/s00508-005-0505-x. Wien Klin Wochenschr. 2006. PMID: 16489526 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters